Pediatric Cancer-Prevent/Reduce Late Stage Side Effects-

Share Button

Aggressive Therapies for Pediatric Cancer Will Result in Long-term and Late Stage Side Effects- 

Conventional oncology has come along way in improving the survival of pediatric cancer patients. Many cancers that were a death sentence fifty years ago are curable today. Unfortunately, with those cures come with the threat of long-term and late stage side effects.

JADE  |  Photographed by Kasia Jarosz

I’m both a parent and a long-term cancer survivor. I live with long-term and late stage side effects from aggressive conventional therapies I underwent in 1995. I live with chronic a-fib, cognitive dysfunction and progressive nerve damage. Research indicates that these side effects could have been either minimized or eliminated all together.

If I knew then what I know now…

Most parents I know would gladly allow treatment-related side effects to their cancer stricken child if the parents were told that their child would live. I feel the same way.

But what if your child was diagnosed with cancer, had to undergo toxic therapies and could also take evidenced-based, non-toxic therapies to reduce their risk of these horrible treatment-related side effects?

To learn more about integrative therapies, those therapies that studies have shown will increase the efficacy of chemo while reducing the collateral damage, scroll down the page, post a question and I will reply ASAP.

Thank you,

David Emerson

  • Long-term Cancer Survivor
  • Cancer Coach
  • Director PeopleBeatingCancer

Chemotherapy-induced hearing loss affects neurocognition in pediatric brain tumor survivors

“More children are surviving malignant brain tumors than in the past, thanks to the use of intense treatments using platinum-based chemotherapy (cisplatin and high-dose carboplatin). Unfortunately, the therapy has a known side effect of permanent hearing loss, resulting from damage to the inner ear. Investigators at Children’s Hospital Los Angeles now report that this type of chemotherapy may not only impact hearing, but that the hearing loss may then contribute to long-term neurocognitive deficits

Among brain tumor survivors treated with platinum-based therapies, 55 percent sustained sensorineural hearing loss. Independent of radiation therapy effects, patients who experienced hearing loss were found to have significant deficits in intelligence, executive function, and verbal reasoning skills…

The study indicates that children who received radiation therapy and developed hearing loss are at particularly high-risk for neurocognitive decline…”